PIASy, a member of the protein inhibitor of activated STAT (PIAS) family, represses the transcriptional activity of the androgen receptor (AR). In this report, we investigate the mechanism of PIASy-mediated repression of AR. We show that AR binds to the RING-finger like domain of PIASy. PIASy contains two transcriptional repression domains, RD1 and RD2. RD1, but not RD2, is required for PIASy-mediated repression of AR. We show that the RD1 domain binds HDAC1 and HDAC2 and that HDAC activity is required for PIASymediated AR repression. PIAS proteins possess small ubiquitin-related modifier (SUMO) E3 ligase activity. Conjugation of SUMO-1 to AR has been implicated in the regulation of AR activity. We examine if the SUMO ligase activity of PIASy is required for PIASy to repress AR. We show that a mutant PIASy, defective in promoting sumoylation, retains the ability to repress AR transcription. In addition, mutation of all the known sumoylation acceptor sites of AR does not affect the transrepression activity of PIASy on AR. Our results suggest that PIASy may repress AR by recruiting histone deacetylases, independent of its SUMO ligase activity.
Introduction
The androgen receptor (AR) plays an important role in many normal and abnormal physiologic processes. Aberrant activation of the androgen-signaling pathway is central to prostate cancer development and progression. The molecular details responsible for the tissueand ligand-specific control of androgen signaling remain largely unknown. However, a complex network of interactions between AR and accessory proteins are thought to explain the tight physiologic control of androgen signaling.
The protein inhibitor of activated STAT (PIAS) family was originally identified in a screen for proteins that interact with signal transducer and activator of transcription (STAT) (Shuai and Liu, 2003) . PIAS1 and PIASy inhibit Stat1 through distinct mechanisms (Liu et al., 1998; Liu et al., 2001) . PIAS3 specifically inhibits Stat3 (Chung et al., 1997) . Our laboratory and others have studied the interaction between AR and PIAS family members in the regulation of AR signaling. The PIAS family is unique among AR-interacting proteins in that related proteins exhibit strikingly different effects on AR-mediated gene transcription. PIAS1 and ARIP3/PIASxa have been shown to function as activators of androgen signaling (Moilanen et al., 1999; Tan et al., 2000) . In contrast, PIASy is a potent inhibitor of AR . PIASy interacts with the AR DNA-binding domain (DBD), but does not inhibit the ability of AR to bind to DNA. PIAS proteins are highly expressed in androgen-dependent tissues, including Sertoli cells and spermatagonia in the testes (Moilanen et al., 1999; Tan et al., 2000) . A role for PIAS family members in the normal physiology of AR is further supported by the observation that the temporal pattern of expression corresponds with AR expression and function during rat testes development (Tan et al., 2002) .
The conjugation of small ubiquitin-related modifier (SUMO) to a variety of target proteins has recently been implicated in a variety of cellular processes, such as nuclear transport, signal transduction, apoptosis, autophagy, cell cycle control, and protein degradation (reviewed in Melchior, 2000) . Recent studies point towards a potential role of PIAS family members as E3-like ligases that control the conjugation of SUMO (sumoylation) to critical target proteins, such as p53, cJun, and LEF1 (Kahyo et al., 2001; Sachdev et al., 2001; Kotaja et al., 2002; Schmidt and Muller, 2002) . PIAS proteins share a highly homologous central RINGfinger like domain (RFD) that is required for their SUMO ligase activity (Aravind and Koonin, 2000; Johnson and Gupta, 2001 ). AR has recently been shown to be a target of sumoylation (Poukka et al., 2000; Nishida and Yasuda, 2002) . Consensus SUMO acceptor sites were identified in the amino-terminal region of AR that overlap with transcriptional synergy control motifs (Iniguez-Lluhi and Pearce, 2000) . Sumoylation is promoted by the addition of androgenic ligands and mutations which abolish sumoylation result in a slightly more transcriptionally active AR mutant, suggesting that sumoylation maybe involved in the downregulation of AR transcription (Poukka et al., 2000; Nishida and Yasuda, 2002) .
This report describes our efforts to understand the molecular mechanism of PIASy-mediated AR repression. We show that PIASy directly interacts with AR and demonstrate that the RFD mediates the PIASy-AR interaction. We identify two distinct repression domains in PIASy, named RD1 and RD2. RD1, but not RD2, is required for PIASy-mediated AR repression. We show that PIASy physically interacts with HDAC1 and HDAC2 and that histone deacetylase activity (HDAC) is required for PIASy-mediated AR repression. We examine the involvement of the PIASy-associated SUMO ligase activity in the regulation of AR transcription. We show that mutations that abolish the SUMO ligase activity of PIASy and sumoylation acceptor sites in AR do not affect the ability of PIASy to inhibit AR signaling. Our data suggest that sumoylation is not involved in the transrepression of AR transcription by PIASy.
Results

PIASy directly binds to AR via the RFD
It has been shown that PIAS proteins can interact with an isolated portion of AR, namely the DNA-binding domain (Moilanen et al., 1999; Tan et al., 2000; Gross et al., 2001) . To examine if PIASy interacts with fulllength AR in mammalian cells and to identify the AR interaction domain of PIASy, a GST-affinity binding assay was performed. A vector was designed to express full-length PIASy fused to GST (GST-PIASy). Cells were transfected with expression vectors for Flag-AR, GST, and GST-PIASy as indicated (Figure 1a ). Lysates were incubated with glutathione-sepharose beads, thoroughly washed, and the association of AR with GST-PIASy was analysed by immunoblotting with anti-Flag antibody. The results show that full-length AR strongly interacts with GST-PIASy, but not GST alone.
To identify the region of PIASy responsible for the interaction with AR, GST fusion proteins were constructed which express various portions of PIASy joined in-frame to GST. Similar GST-pull down analysis was performed to analyse the binding of PIASy domains to AR. The results show that a 70-amino-acid region encompassing the RFD of PIASy was sufficient to mediate the interaction with AR (Figure 1b) . GSTPIASy fusion proteins with deletions of the RFD domain show no significant binding to AR. We conclude that the RFD domain of PIASy mediates the PIASy-AR interaction.
PIASy RFD is required for the PIASy-mediated AR repression
If the RFD of PIASy is responsible for interacting with AR, then removing the RFD should abolish the ability of PIASy to repress AR. Therefore, we generated a PIASy mutant that contains an internal deletion of the 70 amino-acid region required for the AR interaction (PIASyDRFD). The effect of this mutant on AR transcription was examined by luciferase reporter assays in 293T cells. Consistent with our earlier findings, wildtype PIASy is a potent repressor of AR . However, PIASyDRFD failed to inhibit ARmediated transcription (Figure 2a ). Western blot analysis confirmed comparable expression of wild-type and mutant PIASy proteins (Figure 2b ). These results are consistent with the finding that the RFD of PIASy directly interacts with AR.
PIASy possesses distinct transcriptional repression domains
PIASy has been found to repress diverse classes of transcription factors including AR, Stat1, LEF1, and Nelson et al., 2001; Sachdev et al., 2001) . We examined if PIASy contains intrinsic repressor domains. A strategy to identify transcriptional repression domains is to construct fusion proteins which contain a heterologous DNA binding domain, such as the GAL4-DBD, fused to putative repression domains from a protein of interest (Zamir et al., 1997; Ordentlich et al., 1999; Kotaja et al., 2000) . The effect of these fusion proteins on the transcriptional activity of a reporter containing five copies of the GAL4 response element was examined. 293T cells were transiently transfected with expression vectors for GAL4-DBD, GAL4-DBD-PIASy, and GAL4-DBD fused to various portions of PIASy ( Figure 3a ). As expected, GAL4-DBD-PIASy strongly repressed transcription ( Figure 3b ). The removal of amino-acid residues 1-355 completely abolished the trans-repression activity of PIASy. Further deletional analysis uncovered two transcriptional repression domains within the aminoterminal region of PIASy. The first repression domain (RD1) spans residues 1-100 and includes an alphahelical LXXLL motif that we have previously shown to be essential in AR-and Stat1-mediated repression Liu et al., 2001) . In addition, a second repression domain (RD2) is identified spanning residues 268-336 in the region immediately before the RFD. The GAL4-DBD-PIASy fusion protein can repress transcription in the presence of either the RD1 or RD2 domain ( Figure 3b ). Therefore, RD1 and RD2 are distinct transcriptional repression domains present in PIASy.
We next examined the roles of RD1 and RD2 domains in the repression of AR transcription by PIASy. Expression constructs encoding PIASy mutants lacking either RD1 (PIASy(268-510)) or RD2 (PIASyDRD2) were generated. The ability of these PIASy mutants to influence AR-mediated gene activation was examined by transient reporter assays (Figure 4) . Interestingly, while PIASy(268-510) failed to repress ARmediated gene activation, the deletion of the RD2 domain had no effect on the ability of PIASy to repress AR. These results suggest that RD1, but not RD2, is required for PIASy to repress AR transcription.
To confirm that removal of the RD1 domain does not affect the ability of PIASy to interact with AR, we examined the interaction of PIASy(268-510) with AR using a GST-affinity matrix assay. PIASy(268-510) bound to GST-ARDBD equally as well as full-length PIASy (Figure 5a ). We reasoned that if PIASy(268-510) is able to bind to AR but cannot repress AR transcription, it might display a dominant-negative effect on PIASy-mediated repression of AR. To test this hypothesis, PIASy(268-510) was transfected into 293T cells alone or together with wild-type PIASy. Coexpression of PIASy(268-510) with PIASy dramatically reduced the repressive effect of wild-type PIASy on AR-mediated luciferase activity (Figure 5b ). Western blot analysis of the same samples confirmed the proper expression of wild-type and mutant PIAS proteins (Figure 5c ). This is consistent with the conclusion that the RD1 domain of PIASy is a transcriptional repression domain that is required for PIASy to repress AR transcription. 
PIASy interacts with HDAC1 and HDAC2
HDACs are found in many repressor complexes and are part of a general mechanism of transcriptional repression in a wide variety of transcriptional contexts (Xu et al., 1999) . We hypothesized that PIASy-mediated AR repression may involve the recruitment of HDACs. 293T cells were transfected with expression vectors for GST, GST-PIASy, and GST-PIASy(1-90), GSTPIASy(407-510) with or without Flag-HDAC1 (Figure 6a ). Lysates were incubated with glutathionesepharose beads. The beads were thoroughly washed and retained proteins analysed by immunoblotting. The results show that full-length PIASy physically interacts with HDAC1. There is no interaction with GST alone or GST-PIASy(407-510). Similar results were obtained when we examined the interaction of GST-PIASy and GST-PIASy domains with Flag-HDAC2 (Figure 6b) . We conclude that the amino-terminal portion of PIASy (residues 1-90 containing the majority of the RD1 domain) is sufficient to mediate the interaction between PIASy and HDAC1/HDAC2.
If PIASy directly interacts with HDACs, then inhibition of HDAC activity should be able to overcome PIASy-mediated AR repression. The transient transfection assay was used to test this hypothesis (Figure 7 ). AR and ARE4xLuc constructs were transfected into 293T cells with an empty vector or a PIASy expression vector. Transfected cells were stimulated with 1 nM R1881 in the presence or absence of TSA, as indicated. Stimulation with 1 nM R1881 was associated with an increase in luciferase activity that is not appreciably changed by the presence of 100 nM TSA. As expected, PIASy inhibited the R1881-induced ARE reporter activity. However, simultaneous treatment with TSA overcomed the PIASy-mediated repression of AR signaling. Thus, TSA is able to reverse the PIASymediated AR repression. Taken together, these results suggest that PIASy directly interacts with HDAC1/2 through the amino-terminal RD1 domain, and that this interaction and HDAC-activity are required for PIASymediated AR repression.
Sumoylation is not required for PIASy-mediated AR repression
Protein sumoylation plays a role in the function and stability of many target proteins (Melchior, 2000) . 
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A tryptophan residue in the RFD of PIAS family members is required for the SUMO activity of PIASxa/ ARIP3 (Kotaja et al., 2002) . Site directed mutagenesis was used to generate the corresponding PIASyW363A mutant. Cotransfection with Myc-tagged SUMO-1 in 293T cells demonstrated that PIASy potentiated the transfer of SUMO to many target proteins, and that this activity was defective in the PIASyW363A mutant ( Figure 8a ). We next investigated if the PIASy SUMO ligase activity was required for AR repression. PIASy and PIASy W363A were expressed at comparable levels in 293T cells and the effect on R1881-stiumulated AR transcriptional activity was examined (Figure 8b ). The results show that both PIASy and PIASyW363A were equally effective at inhibiting AR-dependent transcription. We conclude that the PIASy-associated SUMOligase activity is not required for AR repression.
To examine the possibility that sumoylation was indirectly linked to AR repression, we generated an AR mutant unable to be a target of sumoylation (Poukka et al., 2000) . A combination of in vitro and in vivo assays identified two lysine residues within (I/L/V)KXE sumoylation acceptor sites (K386 and K520) located in the amino-terminal region of AR (Johnson and Blobel, 1999; Sternsdorf et al., 1999; Poukka et al., 2000) . A mutant AR in which K386 and K520 were replaced with arginine (AR-RR) was generated. The ability of the AR-RR mutant to activate transcription in the presence or absence of PIASy was examined by reporter assays. Consistent with earlier observations, AR-RR was able to activate transcription (Figure 9a ). However, we did not observe a significant difference in the transcriptional activity between wild-type AR and the AR-RR mutant (data not shown). Coexpression of PIASy with AR-RR significantly repressed the ability of AR-RR to activate transcription. The magnitude of repression by PIASy on AR-RR was comparable with that on wild-type AR. Western blot analysis of the same samples showed proper expression of PIASy and AR proteins (Figure 9b ). These results suggest that sumoylation of AR is not involved in PIASy-mediated repression. 
Discussion
This paper reports the characterization of the molecular mechanism of PIASy-mediated repression on AR transcription. Our studies reveal several significant findings: (1) the RFD mediates the interaction of PIASy with full-length AR; (2) PIASy contains two transcriptional repression domains, but only the most aminoterminal of these is required for AR repression; (3) PIASy interacts with HDAC1/2 through the RD1 domain; (4) HDAC-activity is required for PIASymediated AR repression; and (5) PIASy-mediated repression of AR is independent of sumoylation.
The central portion of the PIAS family, including the RFD region, is the most highly conversed region among PIAS family members (Liu et al., 1998) . Multiple studies have shown that the RFD region is a particularly important domain in mediating the binding of PIAS family members to other proteins. The RFD is required for the interaction of both ARIP3/PIASxa and PIAS1 with Ubc9, the E2 SUMO conjugating enzyme (Kotaja et al., 2002; Nishida and Yasuda, 2002) . The RFD also mediates the interaction of ARIP3/PIASxa with the nuclear receptor coactivator, GRIP-1 (Kotaja et al., 2002) . The finding that the RFD also mediates the interaction of PIASy with AR highlights the need to further explore how sequences within the RFD may determine the specificity of the interaction of PIAS family members with different protein targets.
We have identified two transcriptional repression domains of PIASy. We show that the most aminoterminal of these is required for PIASy to repress AR. This is consistent with our previous observation that an LXXLL motif contained within the RD1 domain is required for repression of AR and Stat1 Gross et al., 2001) . The RD1 domain also contains a motif that has been suggested to interact with the PIASy inhibition of AR M Gross et al nuclear matrix (Sachdev et al., 2001; Tan et al., 2002) . It is not known if the nuclear matrix attachment activity of PIASy may contribute to its repression on AR. In contrast to PIASy, PIAS1 and PIAS3 enhance the transcriptional activity of AR . Interestingly, an RD1-related domain is also present in PIAS1 and PIAS3. It remains to be determined if theRD1-related domain is involved in the enhancement of AR-mediated transcription by PIAS1 and PIAS3.
We show that PIASy can directly interact with HDAC1 and HDAC2. HDACs are found in many repressor complexes and are part of a general mechanism of transcriptional repression in a wide variety of transcriptional contexts (Xu et al., 1999) . PIASy has been found to be a potent repressor for diverse classes of transcription factors including AR, Stat1, LEF1, and p53 Nelson et al., 2001; Sachdev et al., 2001) . Our results suggest that PIASy may recruit HDACs or HDAC-containing corepressor complexes as a mechanism of AR repression.
It has been suggested that the SUMO ligase activity of PIAS proteins may be involved in the regulation of several transcription factors. We have directly tested if the SUMO ligase activity of PIASy is involved in AR repression. We show that a mutant PIASy that is defective in SUMO ligase activity retains the ability to repress AR transcription. In addition, mutation of all known sumoylation acceptor sites does not affect the transrepression activity of PIASy on AR. Our results suggest that sumoylation is not required for PIASy to repress AR transcription.
Materials and methods
Plasmids
The mammalian expression vector pEBG was produced by inserting the coding sequence of glutathione-S-transferase (GST) upstream of the EF-1a promoter in pEBB (Mizushima and Nagata, 1990) . The mammalian expression vector pCDNA3-Gal4 was produced by subcloning the coding sequences corresponding to residues 1-147 of Gal4 (Emami and Carey, 1992) into the BamHI/EcoRI sites of pCDNA3 (Invitrogen). Plasmids designed to express GST-PIASy or Gal4-PIASy chimeric proteins were produced by subcloning the desired region of PIASy into the BamHI/NotI sites of pEBG and pCDNA3-Gal4, respectively.
A PCR-based strategy was used to generate PIASyDRFD, PIASyW363A, PIASy(268-510), and PIASyDRD2 based on the Flag-PIASy vector . Flag-AR was produced by cloning the coding sequence from pBS-fAR (Huang et al., 1999) into the XbaI site of pCDNA3 (Invitrogen). A PCR-based mutagenesis strategy was used to generate Flag-AR-RR. Individual primer sets were designed to introduce AAG to AGG mutation corresponding to the Lys-386 to Arg and AGG to AGA corresponding to the Lys-520 to Arg mutations described by Poukka et al. (2000) . All mutations were confirmed by standard sequencing reactions. Flag-HDAC1 was produced by cloning HDAC1 (a gift from Dr Eisenman (Laherty et al., 1997) ) into the BamHI/SalI sites of pCF. Flag-HDAC2 has been previously described (Laherty et al., 1997) . The PSA E-Luc, ARE(4x) E-Luc, and GAL4(5x) E-Luc reporter vectors have also been described previously Wu et al., 2001; Zhang et al., 2002) .
Cell culture
293T cells were maintained in DMEM. Media was supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 mg/ml streptomycin (Invitrogen/Life Technologies). Trichostatin A (TSA) was purchased from SigmaAldrich (St Louis, MO, USA).
Gst-affinity matrix binding assays
293T cells were transiently transfected with Flag-AR or Flag-HDAC1 and equal amounts of pEBG, pEBG-PIASy, or pEBG-PIASy deletion constructs. Cells were lysed in buffer containing 150 mM NaCl, 50 mM Tris pH 8.0, 0.5% NP-40, 10% glycerol, 1 mM EDTA with proteinase inhibitors (1 mg/ml aprotonin, 1 mg/ml leupeptin, 1 mM PMSF). For AR interaction assays, an equal portion of each lysate (50 ml) was added to 450 ml of binding buffer (100 mM NaCl, 25 mM Tris pH 7.5, 1 mM EDTA, 1% Triton X-100, 10 mM NaF, 0.5 mM DTT) with proteinase inhibitors. A measure of 30 ml of glutathionesepharose 4B beads (Amersham Biosciences) were added to each binding mixture and the samples were rotated at 41C for 1-2 h. For HDAC1 interaction assays, 50 ml of glutathionesepharose beads were added directly to lysates. The beads were washed four to five times with binding buffer followed by one wash with 100 mM NaCl/25 mM Tris pH 7.5 or PBS. SDSsample buffer was added and the samples were boiled. Bound proteins were analysed by immunoblotting. In vitro GST-pull down assays with 35 S-labeled proteins were performed as previously described ).
Transfection and reporter assays
293T cells were transiently transfected with equal amounts of pCDNA3-Gal4, Gal4-PIASy, or Gal4-PIASy mutants along with Gal4(5x)-Luc. An expression vector for b-galactisidase was included in each well to control for transfection efficiency. Cells were harvested 28-36 h after transfection and luciferase activity was determined according to the manufacture's instruction (Promega Corp.) The activity of each Gal4-PIASy construct determined relative to the pCDNA3-Gal4 control was determined for each experiment and the values were averaged over at least three independent experiments. Androgen signaling was monitored in 293T cells transfected with Flag-AR and PSA-E Luc or ARE (4x) Luc as previously described . Cells were transfected via the calcium phosphate method and then grown in DMEM supplemented with 5% charcoal-dextran treated FBS (Omega Scientfic) with or without 1 nM R1881 for an additional 24 h. Luciferase activity was determined relative to b-galactosidase activity. Fold induction is defined as the relative luciferase activity of stimulated versus unstimulated paired samples. Each experiment was repeated at least three times, and one representative experiment is shown.
